Bill > SSB1177

Introduced Session

This bill relates to the controlled substance crystalline polymorph psilocybin. Current law categorizes the controlled substance psilocybin as a schedule I, hallucinogenic substance (Code section 124.201(4)(s)). The bill provides that notwithstanding Code section 124.204(4), a drug that contains the pharmaceutical composition of crystalline polymorph psilocybin shall be immediately removed from schedule I upon its approval by the United States food and drug administration and rescheduled based upon the recommendations of the United States food and drug administration and its listing in the federal Controlled Substances Act. The bill provides that upon the rescheduling of psilocybin, S.F. _____ it shall be lawful to prescribe, distribute, and market the pharmaceutical composition of crystalline polymorph psilocybin. Current penalties for the possession of psilocybin range from a serious misdemeanor to a class “B” felony.

Committee Categories

No sponsors listed

Other Sponsors (1)

Subcommittee: Klimesh, Rowley, and Wahls. (on 02/24/2025)

Official Document